Metformin use among patients with type 2 diabetes and renal impairment

被引：0
|
作者：
Sun, S. X. [1 ]
Bron, M. [1 ]
Spanheimer, R. [2 ]
Hudgens, S. [1 ]
Ramalakar, R. [1 ]
Hariri, A. [2 ]
机构：
[1] Takeda Pharmaceut Int Inc, Deerfield, IL USA
[2] Takeda Pharmaceut N Amer Inc, Deerfield, Lyon Bron, France
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1264
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Use of metformin is associated with lower incidence of cancer in patients with type 2 diabetes
    Muszynska-Oglaza, Alicja
    Zarzycka-Lindner, Grazyna
    Olejniczak, Henryka
    Polaszewska-Muszynska, Miroslawa
    Junik, Roman
    ENDOKRYNOLOGIA POLSKA, 2017, 68 (06) : 652 - +
  • [32] Association between pancreatic cancer and metformin use in patients with type 2 diabetes
    Lai, Shih-Wei
    Tsai, Chia-Hsun
    Lin, Cheng-Li
    Liao, Kuan-Fu
    POSTGRADUATE MEDICAL JOURNAL, 2019, 95 (1123) : 291 - 291
  • [33] Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
    Yen, Fu-Shun
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    Hwu, Chii-Min
    Lo, Yu-Ru
    Shin, Shyi-Jang
    Hsu, Chih-Cheng
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (01) : 311 - 322
  • [34] Metformin use and cervical cancer risk in female patients with type 2 diabetes
    Tseng, Chin-Hsiao
    ONCOTARGET, 2016, 7 (37) : 59548 - 59555
  • [35] New Recommendations for Use of Metformin in Renal Impairment
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1493): : 51 - 51
  • [36] Pharmaceutical intervention in metformin prescribing in patients with type 2 diabetes mellitus and renal insufficiency
    Velez-Diaz-Pallares, Manuel
    Cuesta-Lopez, Isabel
    Alvarez-Diaz, Ana
    Perez-Menendez-Conde, Covadonga
    Delgado-Silveria, Eva
    Bermejo-Vicedo, Teresa
    AVANCES EN DIABETOLOGIA, 2014, 30 (01): : 17 - 22
  • [37] Safety and efficacy of sitagliptin compared with dapagliflozin in patients with type 2 diabetes, mild renal impairment, and inadequate glycaemic control on metformin ± a sulfonylurea
    Raji, A.
    Scott, R.
    Morgan, J.
    Zimmer, Z.
    Lam, R. L. H.
    O'Neill, E. A.
    Kaufman, K. D.
    Engel, S. S.
    DIABETOLOGIA, 2018, 61 : S379 - S380
  • [38] Review of Metformin Use for Type 2 Diabetes Prevention
    Moin, Tannaz
    Schmittdiel, Julie A.
    Flory, James H.
    Yeh, Jessica
    Karter, Andrew J.
    Kruge, Lydia E.
    Schillinger, Dean
    Mangione, Carol M.
    Herman, William H.
    Walker, Elizabeth A.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2018, 55 (04) : 565 - 574
  • [39] Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment
    Shira Perl
    William Cook
    Cheryl Wei
    Nayyar Iqbal
    Boaz Hirshberg
    Diabetes Therapy, 2016, 7 : 527 - 535
  • [40] Circulating metabolites improve the prediction of renal impairment in patients with type 2 diabetes
    Trischitta, Vincenzo
    Mastroianno, Mario
    Scarale, Maria Giovanna
    Prehn, Cornelia
    Salvemini, Lucia
    Fontana, Andrea
    Adamski, Jerzy
    Schena, Francesco Paolo
    Cosmo, Salvatore De
    Copetti, Massimiliano
    Menzaghi, Claudia
    BMJ OPEN DIABETES RESEARCH & CARE, 2023, 11 (05)
12345